You are not currently logged in.
Access JSTOR through your library or other institution:
Antiinflammatory Cytokine Responses during Clinical Sepsis and Experimental Endotoxemia: Sequential Measurements of Plasma Soluble Interleukin (IL)-l Receptor Type II, IL-10, and IL-13
Tom van Der Poll, René de Waal Malefyt, Susette M. Coyle and Stephen F. Lowry
The Journal of Infectious Diseases
Vol. 175, No. 1 (Jan., 1997), pp. 118-122
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/30130001
Page Count: 5
You can always find the topics here!Topics: Receptors, Sepsis, Cytokines, Endotoxins, Interleukins, Blood plasma, Septic shock, Tumor necrosis factors, Endotoxemia, Hospital admissions
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
Plasma concentrations of soluble interleukin (IL)-l receptor type II, IL-10, and IL-13 were measured in 42 patients with clinically defined sepsis during a 3-day follow-up and in 7 healthy humans after intravenous injection of endotoxin (2 ng/kg). Levels of soluble IL-1 receptor type II were persistently elevated in patients with sepsis than in healthy controls and higher in nonsurviving patients (n = 22) than in surviving patients (n = 20) at all time points. IL-10 was found in the circulation of 81% of patients with sepsis, while it was not detectable in normal plasma. During follow-up, IL-10 remained invariably high only in nonsurviving patients, while it significantly decreased in survivors. Endotoxin induced IL-10, while soluble IL-1 receptor type II remained unchanged. IL-13 remained undetectable in the vast majority of patients and was not induced by endotoxin. Enhanced IL-13 production does not seem to be part of an inducible host defense mechanism during sepsis.
The Journal of Infectious Diseases © 1997 Oxford University Press